Johnson & Johnson encourages innovation in Queensland
23 June, 2016The Johnson & Johnson Innovation Partnering Office @ QUT aims to improve access to global health and medical innovation in Queensland and beyond.
Stem cell company prepares for Phase 1 clinical trial
22 June, 2016Cynata Therapeutics intends to file an application for regulatory approval with the MHRA for a Phase 1 clinical trial of CYP-001, the company's lead Cymerus mesenchymal stem cell (MSC) product.
Improved drug delivery inside cells
15 June, 2016Drug delivery company Phylogica has announced the improved delivery of antisense oligonucleotide drugs inside cells.
Hayfever trial to commence this month
09 June, 2016Paradigm Biopharma has announced a series of updates surrounding its clinical trial program for hayfever, which will, for the first time, see pentosan polysulfate sodium (PPS) delivered intranasally in human volunteers.
New GHIT Fund partnerships enable R&D investment
07 June, 2016The Global Health Innovative Technology Fund (GHIT Fund) has announced funding partnerships with 10 new organisations, including major global pharmaceutical and biotechnology companies.
Biotech CEOs are optimistic about 2016
01 June, 2016According to the 2016 Biotechnology Industry Position Survey of industry CEOs, biotechnology is front and centre of Australia's post-mining boom economic transition.
QBiotics presents its veterinary cancer compound
01 June, 2016QBiotics has outlined the latest clinical developments in cancer compound EBC-46 to an audience of veterinary cancer experts.
CSL celebrates dual FDA approvals
31 May, 2016CSL has received US FDA approval for two of the biotherapeutics company's products.
Peptides offer prospects for Alzheimer's treatment
30 May, 2016Biotech company Alzhyme has licensed a range of peptides, developed at the University of Tasmania, which have the potential to treat Alzheimer's disease.
AusCann and Murdoch Uni sign medical cannabis research alliance
25 May, 2016AusCann has announced a five-year research alliance with Murdoch University, intended to lead to the development of projects in the field of medicinal cannabis.
Biotron boasts anti-Zika drug compounds
23 May, 2016Shares in Biotron jumped 25% as the company announced that two compounds from its library have shown positive activity against Zika virus.
Australia's edge in early-phase clinical trials
20 May, 2016Cost, regulatory speed and flexibility and quality are the key drivers for biopharma companies selecting Australia for early-phase trials, according to a new report.
Diabetes monitoring through human sweat
19 May, 2016Korean scientists have created a wearable patch that allows accurate diabetes monitoring and feedback therapy by using human sweat.
Helping wrist fractures heal faster
17 May, 2016IPAS and Austofix have collaborated on the development the VRP 2.0 (Volar Radius Plate) — an innovative device that will help wrist fractures heal faster and can be fitted more easily by surgeons.
Enrolment completed in stem cell trial for osteoarthritis
16 May, 2016Regeneus has completed the enrolment of all 20 patients in its STEP trial — the first clinical trial of its allogeneic off-the-shelf MSC product for the treatment of knee osteoarthritis.
